|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/706 | (2006.01) |
| A61K 31/7068 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 4069254 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21761883.4 |
| Date of filing the European patent application | 2021-02-24 | |
| (97) | Date of publication of the European application | 2022-10-12 |
| (45) | Date of publication and mention of the grant of the patent | 2024-09-11 |
| (46) | Date of publication of the claims translation | 2024-10-10 |
| (86) | Number | PCT/US2021/019310 |
| Date | 2021-02-24 |
| (87) | Number | WO 2021/173598 |
| Date | 2021-09-02 |
| (30) | Number | Date | Country code |
| 202062981304 P | 2020-02-25 | US |
| (72) |
OGANESIAN, Aram , US
DAVAR, Nipun , US
KOU, Jim Hwaicher , US
|
| (73) |
Otsuka Pharmaceutical Co., Ltd. ,
2-9, Kanda Tsukasa-machi
Chiyoda-ku, Tokyo 101-8535,
JP
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kietos geriamosios vaisto formos, apimančios decitabiną ir cedazuridiną |
| SOLID ORAL DOSAGE FORMS COMPRISING DECITABINE AND CEDAZURIDINE |
| Payment date | Validity (years) | Amount | |
| 2025-01-20 | 5 | 115.00 EUR |
| 2026-02-24 |